| Gastrointestinal and liver manifestations in patients with COVID-19 IC Lee, TI Huo, YH Huang Journal of the Chinese Medical Association 83 (6), 521-523, 2020 | 322 | 2020 |
| Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma PC Lee, CJ Wu, YW Hung, CJ Lee, CT Chi, IC Lee, K Yu-Lun, SH Chou, ... Journal for immunotherapy of cancer 10 (6), e004779, 2022 | 107 | 2022 |
| Predictors of response and survival in immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma PC Lee, Y Chao, MH Chen, KH Lan, CJ Lee, IC Lee, SC Chen, MC Hou, ... Cancers 12 (1), 182, 2020 | 104 | 2020 |
| Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma PC Lee, Y Chao, MH Chen, KH Lan, IC Lee, MC Hou, YH Huang Journal for immunotherapy of cancer 8 (2), e001072, 2020 | 84 | 2020 |
| A new ALBI‐based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma IC Lee, YW Hung, CA Liu, RC Lee, CW Su, TI Huo, CP Li, Y Chao, HC Lin, ... Liver International 39 (9), 1704-1712, 2019 | 83 | 2019 |
| Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatments IC Lee, YH Huang, GY Chau, TI Huo, CW Su, JC Wu, HC Lin International journal of cancer 133 (12), 2895-2902, 2013 | 82 | 2013 |
| Redefining tumor burden in patients with intermediate-stage hepatocellular carcinoma: the seven-eleven criteria YW Hung, IC Lee, CT Chi, RC Lee, CA Liu, NC Chiu, HE Hwang, Y Chao, ... Liver cancer 10 (6), 629-640, 2021 | 51 | 2021 |
| Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease X Zhang, GBB Goh, WK Chan, GLH Wong, JG Fan, WK Seto, YH Huang, ... Liver International 40 (11), 2719-2731, 2020 | 49 | 2020 |
| Determinants of survival after sorafenib failure in patients with BCLC-C hepatocellular carcinoma in real-world practice IC Lee, YT Chen, Y Chao, TI Huo, CP Li, CW Su, HC Lin, FY Lee, ... Medicine 94 (14), e688, 2015 | 46 | 2015 |
| IL28B polymorphism correlates with active hepatitis in patients with HBeAg-negative chronic hepatitis B IC Lee, CH Lin, YH Huang, TI Huo, CW Su, MC Hou, HC Huang, KC Lee, ... PLoS One 8 (2), e58071, 2013 | 45 | 2013 |
| Lenvatinib plus pembrolizumab for systemic therapy-naïve and-experienced unresectable hepatocellular carcinoma CJ Wu, PC Lee, YW Hung, CJ Lee, CT Chi, IC Lee, MC Hou, YH Huang Cancer Immunology, Immunotherapy 71 (11), 2631-2643, 2022 | 39 | 2022 |
| Comparative analysis of noninvasive models to predict early liver fibrosis in hepatitis B e Antigen-negative Chronic Hepatitis B IC Lee, CC Chan, YH Huang, TI Huo, CJ Chu, CR Lai, PC Lee, CW Su, ... Journal of clinical gastroenterology 45 (3), 278-285, 2011 | 39 | 2011 |
| CXCL9 associated with sustained virological response in chronic hepatitis B patients receiving peginterferon alfa-2a therapy: a pilot study IC Lee, YH Huang, CW Su, YJ Wang, TI Huo, KC Lee, HC Lin PLoS One 8 (10), e76798, 2013 | 34 | 2013 |
| Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B IC Lee, YH Huang, CC Chan, TI Huo, CJ Chu, CR Lai, PC Lee, CW Su, ... Clinical Nutrition 30 (5), 647-652, 2011 | 34 | 2011 |
| Hepatitis B virus reactivation after 23 months of rituximab-based chemotherapy in an HBsAg-negative, anti-HBs-positive patient with follicular lymphoma IC Lee, YH Huang, CJ Chu, PC Lee, HC Lin, SD Lee Journal of the Chinese Medical Association 73 (3), 156-160, 2010 | 32 | 2010 |
| Evolutionary learning-derived clinical-radiomic models for predicting early recurrence of hepatocellular carcinoma after resection I Lee, JY Huang, TC Chen, CH Yen, NC Chiu, HE Hwang, JG Huang, ... Liver cancer 10 (6), 572-582, 2021 | 31 | 2021 |
| Predictors of long-term recurrence and survival after resection of HBV-related hepatocellular carcinoma: the role of HBsAg IC Lee, HJ Lei, GY Chau, YC Yeh, CJ Wu, CW Su, TI Huo, Y Chao, HC Lin, ... American Journal of Cancer Research 11 (7), 3711, 2021 | 30 | 2021 |
| Incidence and predictors of HBsAg loss after peginterferon therapy in HBeAg-negative chronic hepatitis B: a multicenter, long-term follow-up study IC Lee, SS Yang, CJ Lee, CW Su, YJ Wang, KH Lan, HC Lin, MC Hou, ... The Journal of infectious diseases 218 (7), 1075-1084, 2018 | 30 | 2018 |
| Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection SH Young, GY Chau, IC Lee, YC Yeh, Y Chao, TI Huo, CW Su, HC Lin, ... Journal of the Formosan Medical Association 119 (1), 218-229, 2020 | 29 | 2020 |
| Abatacept is second to rituximab at risk of HBsAg reverse seroconversion in patients with rheumatic disease MH Chen, IC Lee, MH Chen, MC Hou, CY Tsai, YH Huang Annals of the rheumatic diseases 80 (11), 1393-1399, 2021 | 27 | 2021 |
